Shares of Melodiol Global Health Limited (OTCMKTS:COPHF – Free Report) are going to reverse split on the morning of Wednesday, June 5th. The 1-30 reverse split was announced on Wednesday, June 5th. The number of shares owned by shareholders will be adjusted after the closing bell on Wednesday, June 5th. Melodiol Global Health Price Performance […]
Creso Pharma Limited (OTCMKTS:COPHF – Get Rating) saw a significant growth in short interest in May. As of May 15th, there was short interest totalling 32,000 shares, a growth of 60.0% from the April 30th total of 20,000 shares. Based on an average daily trading volume, of 26,300 shares, the short-interest ratio is presently 1.2 […]
The wholly-owned Creso Pharma subsidiary is currently conducting clinical trials of its synthetic psilocybin formulation as treatment for mental health conditions NEDLANDS, Australia, Feb. 9, 2023 /PRNewswire/ Creso Pharma Limited(ASX:CPH, FRA:1X8) ('Creso Pharma') is pleased to announce its wholly-owned psychedelics subsidiary, Halucenex Life Sciences Inc. ('Halucenex'), is exploring opportunities to register its synthetic psilocybin formulation for the Australian market following recent regulatory changes. The Therapeutic Goods Administration (TGA), the medicine and therapeutic regulatory agency of the Australian Government, recently announced that the medical use of MDMA and psilocybin will be reclassified from Schedule 9 (prohibited substances) to Schedule 8 (controlled medicines). This ruling allows authorized psychiatrists to prescribe medicines containing MDMA and psilocybin for the treatment of certain mental health conditions as of July 1, 2023. Based in Winds
Halucenex Life Sciences Inc targets Australian market following landmark TGA decision streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.